H
YPERTENSION IS A PREVAlent condition affecting approximately 65 million individuals in the United States based on a preliminary report from the National Health and Nutrition Examination Survey (NHANES) [2005] [2006] and coincident US population estimates. 1, 2 Given the prevalence and impact of hypertension on health outcomes and disparities, [3] [4] [5] [6] several national initiatives developed programs, guidelines, and policies to facilitate hypertension prevention, detection/ awareness, treatment, and control. [7] [8] [9] [10] Hypertension control (defined as systolic blood pressure [BP] of Ͻ140 mm Hg and diastolic BP of Ͻ90 mm Hg) increased from 10% in NHANES II (1976) (1977) (1978) (1979) (1980) ) to 31.0% in 1999-2000. 11, 12 Another NHANES analysis reported that hypertension control increased from 25.0% in 1999-2000 to 33.1% in 2003-2004 . 13 A preliminary NHANES [2005] [2006] report noted approximately 44% of all adults with hypertension achieved systolic BP of less than 140 mm Hg and diastolic BP of less than 90 mm Hg. 1 The reports indicate progress toward the Healthy People 2010 national objective of controlling BP in 50% of all individuals with hypertension. 1, 8, 9, [11] [12] [13] However, differences in defining hypertension control and variable age-adjustments limit the capacity to assess changes over time. 12, 13 Moreover, BP data from NHANES 2007-2008 were recently released.
ized US population. All adults provided written informed consent; the study was approved by the National Center for Health Statistics Institutional/ Ethics Review Board. 14, 15 Definitions Race/ethnicity was determined by selfreport and categorized as nonHispanic white (white), non-Hispanic black (black), Hispanic, and other (American Indian, Native Alaskan, Asian or Pacific Islander, and other race not specified). 11, 12 Blood pressure in NHANES 1988 NHANES -1994 NHANES and 1999 NHANES -2008 was measured by physicians trained in the method using mercury sphygmomanometry and appropriately sized arm cuffs after volunteers rested 5 minutes seated. [14] [15] [16] [17] [18] [19] Individuals without recorded BP were excluded. In determining mean BP for individuals, the first BP was used if only 1 measurement was obtained. The second BP was used if 2 readings were taken; second and third values were averaged when available. 13, [15] [16] [17] [18] [19] The percentage of individuals with 3 systolic BP readings varied from 81. Prevalent hypertension was defined as mean systolic BP of at least 140 mm Hg, mean diastolic BP of at least 90 mm Hg, [20] [21] [22] [23] or both, and/or affirming that participants were currently taking prescription medication to lower BP. [11] [12] [13] [14] Awareness of hypertension was determined by patients with hypertension responding affirmatively to the question, "Have you ever been told by a doctor or other healthcare professional that you had hypertension, also called high blood pressure?" [11] [12] [13] [14] Treatment of hypertension was established by participants responding yes to the question, "Because of your hypertension/high blood pressure, are you now taking prescribed medicine?" [11] [12] [13] [14] Control of hypertension was defined as systolic BP of less than 140 mm Hg and diastolic BP of less than 90 mm Hg based on the Fourth and Fifth Reports of the Joint National Committee (JNC) on Detection, Evaluation, and Treatment of High Blood Pressure.
20,21
The Sixth and Seventh JNC Reports retained the same definition of hypertension control except for lower goals in high-risk subsets, including patients with diabetes.
22, 23 Recent evidence does not strongly support a systolic BP goal of less than 140 mm Hg for patients with diabetes 24 ; therefore, our study focuses exclusively on the goal of systolic BP of less than 140 mm Hg and diastolic BP of less than 90 mm Hg.
Diabetes Mellitus
Diabetes mellitus was defined by a positive response to any of the questions, "Have you ever been told by a doctor that you have diabetes?"; "Are you now taking insulin?"; "Are you now taking diabetes pills to lower your blood sugar?" The definition did not include patients with only fasting plasma glucose of 126 mg/dL or higher (ie, undiagnosed diabetes).
12,13
Data Analysis NHANES Analytic and Reporting Guidelines were followed.
25,26 SUDAAN version 10.0.1 (Research Triangle Institute, Research Triangle Park, North Carolina) accounts for NHANES complex sampling design, estimates mean values and percentages, and provides 95% confidence intervals (CIs) (Taylor series linearization).
All surveys were age-adjusted to the US 2000 census. In 2000, 42% of adults were aged 18 to 39 years, 36% were aged 40 to 59 years, and 22% were 60 years or older, with weights of 0.42, 0.36, and 0.22, respectively, which were used in calculating prevalence. For calculating awareness, treatment, and control, additional weights were calculated, because hypertension prevalence varies by age group. Improvements in awareness, treatment, and proportion of patients who were treated and whose BP was controlled was associated with an increase 
Clinical Epidemiology of Hypertension by Age Group
Prevalent hypertension increased over time in individuals aged 40 to 59 years (P =.02) and 60 years or older (P=.04) but could not be assessed for those 18 to 39 years using weighted linear regression ( Figure 1 ). Prevalent hypertension was greater among individuals aged 60 years or older (PϽ.001) and 40 to 59 years (PϽ.001) than for those 18 to 39 years and was more common in those 60 years or older than for 40 to 59 years (P Ͻ .001). Hypertension awareness increased over time among individuals aged 40 to 59 years (P=.04) and 60 years or older (P=.03) but not for 18 to 39 years (P=.36). Awareness was higher among individuals aged 60 years or older (P Ͻ .001) and 40 to 59 years (PϽ.001) than for those 18 to 39 years but was not different between the 2 older groups (P =.72).
The percentage of patients who were treated for hypertension increased among those aged 40 to 59 years (P=.01) and 60 years or older (P=.03) but could not be assessed for 18 to 39 years. Treatment rates were higher among individuals aged 60 years or older (PϽ.001) and 40 to 59 years (PϽ.001) vs 18 to 39 years and 60 years or older vs 40 to 59 years (P=.03). The proportion of patients who were treated and whose hypertension was controlled increased over time among individuals aged 40 to 59 years (P=.02) 
Clinical Epidemiology of Hypertension by Race and Sex
Prevalent hypertension increased over time in black (P = .04) and white (P=.004) but not Hispanic (P=.65) individuals (FIGURE 2). Prevalent hypertension was greater in black vs white (P Ͻ .001) and Hispanic individuals (P Ͻ .001) but not different between white and Hispanic groups (P = .12). Hypertension awareness increased among black (P=.006), white (P=.04), and Hispanic (P=.03) individuals and was greater in black vs white (P=.004) and Hispanic (PϽ.001) individuals and white vs Hispanic individuals (P=.03).
The proportion of patients with hypertension receiving treatment increased among black (PϽ.001), white (P=.008), and Hispanic (P=.01) individuals. The proportion of individuals who were treated for hypertension was greater among black vs white (P=.009) and Hispanic (PϽ.001) and higher in white vs Hispanic (P=.006). The proportion of patients who were treated and whose hypertension was controlled increased among white (P=.004), black (P=.02), and Hispanic (P=.002) individuals and was higher in white vs black (PϽ.001) and Hispanic (P=.02) but not different in black vs Hispanic (P=.08).
Controlled hypertension increased over time among white (P=.007), black (P=.008), and Hispanic (P=.003) individuals. Blood pressure control was greater in white vs Hispanic (P=.004) individuals but did not differ between black Prevalent hypertension increased over time in men (P = .04) but not women (P=.10) and was not different between men and women (P = .37). Hypertension awareness increased with time in men (P=.04) but not women (P=.09) and was greater in women than men (P=.007). Hypertension treatment increased with time in women (P=.03) and men (P=.004) and was higher in women vs men (P=.001). The proportion of patients treated and whose hypertension was controlled increased in men (PϽ.001) but only marginally in women (P = .05) and was greater in men vs women (P=.02). Controlled hypertension increased with time in women (P=.04) and men (PϽ.001) but did not differ between groups (P=.33).
COMMENT
Hypertension control improved from 27.3% in 1988-1994 to 50.1% in 2007-2008 (P for trend = .006). Hypertension control represents the product of awareness, the proportion of aware patients who were treated, and the proportion of treated patients whose BP was controlled (systolic BP of Ͻ140 mm Hg and diastolic BP of Ͻ90 mm Hg). The progress in BP control reflected increases in awareness (P=.03), treatment (P=.004), and proportion of patients with hypertension treated and controlled (P=.006).
In 2003, achieving the Healthy People 2010 goal of controlling BP in 50% of all patients with hypertension appeared unlikely, 27 given the relatively limited improvement between 1988-1994 and 1999-2000. 11, 12 We proposed that increasing BP control from 31% in 1999-2000 12 to 50% by 2010 could be accomplished with substantial but achievable increases in hypertension awareness, treatment, and proportion of patients with hypertension treated and controlled from 69%, 58%, and 53% in 1999-2000 to 80%, 72%, and 70%, respectively The increase in hypertension control coincided with a significant decrease of systolic and diastolic BP among patients with hypertension between 1988-1994 and 2007-2008 (P = .02 and PϽ.001, respectively). Healthy lifestyles are an unlikely explanation for lower BP and better control among patients with hypertension, because eating patterns became less "DASH-like" 28 and obesity increased over time. 29 Obesity is a characteristic of individuals with treatment-resistant hypertension (ie, BP not controlled by Ն3 antihypertensive medications or controlled by Ն4 BP medications). 30 Despite challenges in controlling BP in patients who are obese, control improved significantly in all obese patients but not in all nonobese patients with hypertension from 1999-2004.
14 In addition to a greater percentage of patients receiving treatment, data suggest that patients with hypertension, especially obese individuals, are receiving more BP medications to explain the increase in proportion of patients who were treated and controlled. Our study did not include detailed treatment analyses to assess this possibility.
Systolic BP decreased over time in individuals with hypertension but increased among individuals without hypertension (P=.02). Adverse changes in nutrition and obesity are likely contributors to higher BP among individuals without hypertension. 14, 23 The prevalence of hypertension is an important public health concern with a Healthy People 2010 goal of 16%. 9 From one-fifth to four-fifths of the increase in prevalent hypertension between 1988-1994 and 1999-2004 was attributed to higher BMI. 14 Time trends in hypertension prevalence, awareness, treatment, and control among all individuals with hypertension were documented in most demographic subsets in our study. Sample size was generally inadequate among individuals aged 18 to 39 years for weighted linear regression to assess changes over the 6 NHANES 1988 6 NHANES -2008 groups. Sample sizes for this group were adequate for weighted t tests comparing 1988-1994 with 2007-2008 and showed significant improvement in the proportion treated (PϽ.001), patients with hypertension treated and controlled (P = .004), and the proportion whose hypertension was controlled (P Ͻ .001). Awareness and treatment were greater in patients with hypertension aged 60 years or older (PϽ.001) and 40 to 59 years (PϽ.001) vs those 18 to 39 years. Our findings coincide with another NHANES report that adults aged 20 to 39 years were less aware of hypertension than older individuals. 31 Poverty and health insurance were not characteristics of individuals who were unaware of their hypertension, although they were more likely to receive only 0 to 1 health care visits in the prior year. In our study, individuals with hypertension aged 18 to 39 years were more likely to attain control when treated vs those 60 years or older (PϽ.001). Data suggest efforts to improve BP control in younger adults should focus on raising awareness and linkage to a primary care medical home.
Among patients aged 60 years or older, hypertension awareness and treatment were relatively high, whereas the proportion of patients with hypertension treated and controlled was lower compared with those 18 to 39 years (PϽ.001) and 40 to 59 years (P=.008). Although our study did not focus on treatment details, older age is a key patient characteristic in treatment-resistant hypertension. 30 Strategies for enhancing treatment effectiveness (proportion of patients with hypertension treated and controlled) emerge as an important factor for improving hypertension control among individuals older than 60 years. While BP control is important, treatment of hypertension in older patients reduces cardiovascular events, even when mean treated systolic BP remained higher than 140 mm Hg. 32, 33 Hypertension awareness, treatment, proportion of patients with hypertension treated and controlled, and the proportion with hypertension controlled improved over time in white, black, and Hispanic groups, but significant disparities persist. The greater prevalence of hypertension in black vs white (PϽ.001) or Hispanic (PϽ.001) individuals is well documented. 1, 6, 11, 12 Awareness of hypertension was higher among black vs white (P = .004) and Hispanic (P Ͻ .001) individuals, and white vs Hispanic individuals (P=.03). Similarly, treatment rates were higher in black vs white (P = .009) and Hispanic (P =.006) individuals, and white vs Hispanic (P=.006) individuals. A different pattern emerged for the proportion of patients whose hypertension was treated and controlled, with higher rates among white vs black (PϽ.001) or Hispanic (P = .02) individuals. Data suggest that initiatives to improve BP control among Hispanic individuals should emphasize screening and referral to a primary care medical home, whereas more emphasis on treatment effectiveness is needed for black individuals.
Hypertension awareness and treatment are higher in women than in men, and the proportion of patients treated and controlled was higher in men vs women. NHANES data suggest that raising hypertension awareness and treatment is important for men, whereas controlling hypertension in patients who are treated is a higher priority for women.
Our study has limitations. Sample size for detecting changes among individuals aged 18 to 39 years was limited and required t tests of the first and last NHANES surveys rather than weighted linear regression encompassing all 6 surveys used for all other demographic groups. The guidelines recommend confirming stage 1 (mild) hypertension at follow-up visits. [20] [21] [22] [23] Blood pressure on a single NHANES assessment may overestimate prevalent hypertension. Blood pressure was measured by a physician and typically provided higher values than measurements by nurses, which would tend to overestimate prevalent hypertension and underestimate control. Because out-of-office BP is not available in most NHANES participants, we excluded the initial reading, which is of-ten the highest value, whenever 2 or more BP measurements were available. Blood pressure decreased significantly between first and second reading and between first and mean of the second and third reading, which served to attenuate the physician BP effect. Despite limitations, BP has been consistently measured during NHANES 1988-2008. Methods for assessing prevalence, awareness, treatment, and control were also consistent, which strengthens the validity of comparisons over time.
In conclusion, hypertension control improved, with most of the progress toward the Healthy People 2010 goal of controlling BP in 50% of all individuals with hypertension occurring between 1999 and 2008. 9 However, prevalent hypertension is not decreasing toward the national goal of 16% and will likely remain high unless adverse trends in population nutrition and BMI occur or pharmacological approaches to hypertension prevention are adopted. 28, 29, 34 Hypertension control improved, despite adverse changes in nutrition and BMI, 28, 29 and reflects increases in awareness, treatment, and patients who were treated attaining target BP, in all individuals with hypertension combined and all age, race, and sex subgroups. However, demographic disparities exist. Broad-based efforts to improve awareness, treatment, and proportion of patients treated and controlled are important for increasing BP control in all groups. Complementary programs to raise awareness and treatment among 18 to 39 years, Hispanic, and male groups and to increase the proportion of patients treated and controlled among 60 years or older, black, and female groups are important for improving hypertension control and reducing disparities.
